ACR Meeting Abstracts

ACR Meeting Abstracts

Abstract Number: 1402

Exceeding Activity Targets but Missing the Mark with Sleep: Mapping 24-Hour Movement Guidelines in Axial Spondyloarthritis

Laura Passalent1, Tina Ko1, Yangqing Deng2, Sunita Mathur3, Mark Abovsky4, Igor Jurisica5, Nigil Haroon6 and Robert Inman7, 1Schroeder Arthritis Institute, University Health Network, Toronto, ON, Canada, 2Department of Biostatistics, University Health Network, Toronto, ON, Canada, 3School of Rehabilitation Therapy, Queen's University, Kingston, ON, Canada, 4Krembil Research Institute, University Health Network, Toronto, ON, Canada, 5Schroeder Arthritis Institute, Krembil Research Institute and Departments of Medical Biophysics and Computer Science and Faculty of Dentistry, University of Toronto and Institute of Neuroimmunology, Slovak Academy of Sciences, Bratislava, Slovakia, 6University of Toronto, University Health Network, Schroeder Arthritis Institute, Department of Medicine/Rheumatology, Toronto, ON, Canada, 7University Health Network, Toronto, ON, Canada

Meeting: ACR Convergence 2023

Keywords: , , , ,

Session Information

Date: Monday, November 13, 2023

Title: (1383–1411) Spondyloarthritis Including Psoriatic Arthritis – Diagnosis, Manifestations, & Outcomes Poster II: Imaging & AS

Session Type: Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: The Canadian 24-Hour Movement Guidelines were recently published in 2022 and integrate evidence-based targets for physical activity, sleep and sedentary behaviours, with recommendations regarding duration, intensity and quality of each activity to achieve health outcomes in adults aged 18-64 years. The purpose of this study was to determine if patients diagnosed with axial spondyloarthritis (axSpA) are meeting these guidelines. The specific objectives were to: 1) profile moderate-vigorous physical activity (MVPA); 2) profile sedentary behaviours and sleep patterns and 3) evaluate discrepancy between objective and subjective measures of activity and sleep.

Methods: Participants with axSpA (meeting ASAS criteria) attending an urban academic rheumatology clinic were provided a wrist-mounted accelerometer, worn for 24 hours over a consecutive 7-day period. The average data validated for a 75% wear-time was used for analysis and included time spent in MVPA per week; time spent in sedentary activity per 24 hours, and sleep/wake duration per 24 hours. Participants completed the International Physical Activity Questionnaire to measure subjective physical activity engagement and a 7-day sleep log to subjectively evaluate sleep quality. Univariate statistics were used to create profiles aligned with the guideline’s core recommendations.

Results: Out of 41 people with axSpA who participated in the study, 37 (90%) had validated accelerometer data.Most participants were male (56.7%); mean age of 46.0 years (SD 12.6); mean disease duration 23.9 years (SD 11.4); mean Bath Ankylosing Spondylitis Disease Activity Index was 3.2 (SD.1); mean Bath Ankylosing Spondylitis Functional Index was 2.6 (SD 2.2). 35.1% had a history of peripheral joint involvement; 56.7% were receiving biologic treatment; 51.3% were receiving non-steroidal anti-inflammatories.All of the cohort met the MVPA targets of a minimum of 150 minutes of MVPA per week (mean 978.5 minutes, SD 387.9) and sedentary behaviour limits of no more than 8 hours daily (mean 5.0 hours, SD 0.9).Only 37.8% of participants met the sleep target of 7 to 9 hours of sleep (mean 6.4 hours, SD 2.0), with multiple disruptions per sleep period (mean 17.7, SD 7.1), indicating poor sleep quality. Participants tended to underestimate their subjective engagement in physical activity and overestimate sleep quality.

Conclusion: The results of this study suggest people with axSpA are highly engaged in physical activity and demonstrate minimal sedentary behaviour, both which exceed recommended activity guidelines. These results are considerably higher when compared to the literature. There is discrepancy between subjective and objective measures of activity and sleep.Sleep quantity and quality are of significant concern, with few people with axSpA meeting recommended targets.Further study that examines sleep-wake patterns, understanding of sleep physiology in this patient population and potential management strategies are recommended to address sleep deficiency in people with axSpA.

Disclosures: L. Passalent: AbbVie/Abbott, 6, Novartis, 6, UCB, 2, 5; T. Ko: None; Y. Deng: None; S. Mathur: None; M. Abovsky: None; I. Jurisica: None; N. Haroon: AbbVie, 2, Eli Lilly, 2, Janssen, 2, Novartis, 2, UCB Pharma, 2; R. Inman: AbbVie, 2, Eli Lilly, 2, Janssen, 2, Novartis, 2, Sandoz, 2.

To cite this abstract in AMA style:

Passalent L, Ko T, Deng Y, Mathur S, Abovsky M, Jurisica I, Haroon N, Inman R. Exceeding Activity Targets but Missing the Mark with Sleep: Mapping 24-Hour Movement Guidelines in Axial Spondyloarthritis [abstract]. Arthritis Rheumatol. 2023; 75 (suppl 9). https://acrabstracts.org/abstract/exceeding-activity-targets-but-missing-the-mark-with-sleep-mapping-24-hour-movement-guidelines-in-axial-spondyloarthritis/. Accessed .

« Back to ACR Convergence 2023

ACR Meeting Abstracts - https://acrabstracts.org/abstract/exceeding-activity-targets-but-missing-the-mark-with-sleep-mapping-24-hour-movement-guidelines-in-axial-spondyloarthritis/